Navigation Links
A new growth factor identified

Scientists have identified a growth factor that triggers blood vessel formation within the endocrine glands. In California, Dr. Jennifer of Genentech Inc. and colleagues reported their discovery of endocrine gland-derived vascular endothelial growth factor, or EG-VEGF. The finding could lead the way toward treatment for illnesses affecting these glands. The endocrine glands produce various hormones such as ovaries, testicles, pancreas, pituitary and thyroid.//

Scientists have known for several years, that a specific protein called VEGF triggers new blood vessel growth throughout the body. This has been investigated as a treatment for heart disease. Since tumors need new blood vessels in to grow, they have also sought to fight cancer by blocking VEGF's action. Unlike VEGF, the researchers also found that EG-VEGF only acts on cells that line the capillaries of the endocrine glands.

According to Dr.Napoleone Ferrara, one of the study authors, they believe that EG-VEGF was implicated in the pathogenesis of some ovarian disorders resulting in infertility, such as the polycystic ovary syndrome and an inhibitor of EG-VEGF may have therapeutic value in this condition.

He also added that the discovery also raises the possibility that other growth factors exist that act on specific tissues, such as the heart or lung or skeletal muscle, which could hold "considerable therapeutic potential.


'"/>




Page: 1

Related medicine news :

1. Anthrax drug doxycycline could stunt fetal growth
2. Zinc may enhance growth in Young sickle cell patients
3. Drug stabilizes cancer growth
4. Enzyme stimulates growth of adult stem cells
5. Mental growth in babies at risk
6. New Molecule that can stop the growth of Viruses
7. New study questions consumption of milk for bone growth
8. New study questions consumption of milk for bone growth
9. Improved height from administration of growth hormones
10. Record growth of Soya-based dairy alternatives in Europe
11. Prostate tumour growth suppressed by flavonoids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... , ... April 25, 2017 , ... Lake Park Dental ... by using Invisalign® in Lutz, FL. With the help of this highly-effective, ... aesthetics with fewer potential complications, more discretion and less pain. , Drs. Sarah ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: